Ming-derg Lai

Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Correction: Severe enterovirus A71 pathogenesis and immune responses in human nucleolin transgenic mice.

Correction: Severe enterovirus A71 pathogenesis and immune responses in human nucleolin transgenic mice.

Journal: Medical microbiology and immunology
Published: August 27, 2025

Aurora-A-mediated cytosolic localization of Maf1 promotes cell proliferation via regulating mitochondrial function in HCC.

Aurora-A-mediated cytosolic localization of Maf1 promotes cell proliferation via regulating mitochondrial function in HCC.

Journal: Cell death discovery
Published: July 20, 2025

Severe enterovirus A71 pathogenesis and immune responses in human nucleolin transgenic mice.

Severe enterovirus A71 pathogenesis and immune responses in human nucleolin transgenic mice.

Journal: Medical microbiology and immunology
Published: April 01, 2025

Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.

Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.

Journal: American journal of cancer research
Published: December 09, 2024

Inhibition of lncRNA RPPH1 activity decreases tumor proliferation and metastasis through down-regulation of inflammation-related oncogenes.

Inhibition of lncRNA RPPH1 activity decreases tumor proliferation and metastasis through down-regulation of inflammation-related oncogenes.

Journal: American journal of translational research
Published: August 21, 2023

Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity.

Neutralizing IL-16 enhances the efficacy of targeting Aurora-A therapy in colorectal cancer with high lymphocyte infiltration through restoring anti-tumor immunity.

Journal: Cell death & disease
Published: August 03, 2023

Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer.

Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer.

Journal: Biomedicines
Published: July 19, 2023

Inactivation of pentraxin 3 suppresses M2-like macrophage activity and immunosuppression in colon cancer.

Inactivation of pentraxin 3 suppresses M2-like macrophage activity and immunosuppression in colon cancer.

Journal: Journal of biomedical science
Published: July 06, 2023

Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate.

Synergistic suppressive effects on triple-negative breast cancer by the combination of JTC-801 and sodium oxamate.

Journal: American journal of cancer research
Published: June 26, 2023

ABCB1 Regulates Immune Genes in Breast Cancer.

ABCB1 Regulates Immune Genes in Breast Cancer.

Journal: Breast cancer (Dove Medical Press)
Published: June 08, 2023

Repurposing nitric oxide donating drugs in cancer therapy through immune modulation.

Repurposing nitric oxide donating drugs in cancer therapy through immune modulation.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 25, 2022

A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment.

A novel combination therapy of arginine deiminase and an arginase inhibitor targeting arginine metabolism in the tumor and immune microenvironment.

Journal: American journal of cancer research
Published: May 09, 2022
Showing 1-12 of 66

Last Updated: 09/26/2026